Corrigendum to “Rational Design of Ruthenium Complexes Containing 2,6-Bis(benzimidazolyl)pyridine Derivatives With Radiosensitization Activity by Enhancing p53 Activation”

IF 3.5 4区 医学 Q2 CHEMISTRY, MEDICINAL
ChemMedChem Pub Date : 2026-09-15 DOI:10.1002/cmdc.70492
Zhiqin Deng, Lianling Yu, Wenqiang Cao, Wenjie Zheng, Tianfeng Chen
{"title":"Corrigendum to “Rational Design of Ruthenium Complexes Containing 2,6-Bis(benzimidazolyl)pyridine Derivatives With Radiosensitization Activity by Enhancing p53 Activation”","authors":"Zhiqin Deng,&nbsp;Lianling Yu,&nbsp;Wenqiang Cao,&nbsp;Wenjie Zheng,&nbsp;Tianfeng Chen","doi":"10.1002/cmdc.70492","DOIUrl":null,"url":null,"abstract":"<p><i>ChemMedChem</i> <b>2015</b>, 10(6): 991–998, https://doi.org/10.1002/cmdc.201500127</p><p>The authors regret the inadvertent errors in Figures 7 and S7. Specifically, the representative caspase-9 band in Figure 7 was incorrectly inserted during figure assembly. In Figure S7, an incorrect representative image was inadvertently used for the control group. The figure legend of Figure S8 was mislabeled, which should be revised as Figure S9.</p><p>Upon verification of the original experimental records and raw data, the correct caspase-9 band and the control cell image have been identified. They are provided in the corrected Figures 7 and S7, respectively.</p><p>This correction does not alter the original data interpretation or the conclusions drawn in this paper.</p><p>The authors apologize for any inconvenience caused.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 18","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13579074/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemMedChem","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cmdc.70492","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

ChemMedChem 2015, 10(6): 991–998, https://doi.org/10.1002/cmdc.201500127

The authors regret the inadvertent errors in Figures 7 and S7. Specifically, the representative caspase-9 band in Figure 7 was incorrectly inserted during figure assembly. In Figure S7, an incorrect representative image was inadvertently used for the control group. The figure legend of Figure S8 was mislabeled, which should be revised as Figure S9.

Upon verification of the original experimental records and raw data, the correct caspase-9 band and the control cell image have been identified. They are provided in the corrected Figures 7 and S7, respectively.

This correction does not alter the original data interpretation or the conclusions drawn in this paper.

The authors apologize for any inconvenience caused.

“合理设计含有2,6-双(苯并咪唑)吡啶衍生物的钌配合物,通过增强p53激活具有放射增敏活性”的勘误表。
ChemMedChem 2015, 10(6): 991-998, https://doi.org/10.1002/cmdc.201500127The作者对图7和S7中的无意错误表示遗憾。具体来说,图7中代表性的caspase-9条带在图组装过程中插入错误。在图S7中,无意中为对照组使用了不正确的代表性图像。图S8图例标注错误,需要修改为图S9。经过对原始实验记录和原始数据的验证,正确的caspase-9波段和对照细胞图像已经被识别出来。它们分别在更正后的图7和S7中提供。这一修正不改变原始数据的解释和本文得出的结论。作者对造成的任何不便表示歉意。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ChemMedChem
ChemMedChem 医学-药学
CiteScore
6.70
自引率
2.90%
发文量
280
审稿时长
1 months
期刊介绍: Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书